NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Propanc Biopharma Inc (OTCQB: PPCB)

 
PPCB Technical Analysis
5
As on 17th Oct 2025 PPCB STOCK Price closed @ 1.58 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.54 & Strong Sell for SHORT-TERM with Stoploss of 2.29 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

PPCBSTOCK Price

Open 1.56 Change Price %
High 1.60 1 Day 0.00 0.00
Low 1.54 1 Week -1.22 -43.57
Close 1.58 1 Month -5.17 -76.59
Volume 71445 1 Year -5.17 -76.59
52 Week High 11.00 | 52 Week Low 1.58
 
OTCQB USA Most Active Stocks
BMIX 0.01 %
FMCC 4.94 12.53%
ALPP 3.56 -100.00%
ALPP 3.56 -100.00%
CBDS 0.06 -25.00%
VKIN 0.23 0.00%
SRNA 2.78 14.88%
TSSI 8.63 -8.77%
CYDY 0.13 0.00%
TMRC 1.83 490.32%
 
OTCQB USA Top Gainers Stocks
EMMLF 0.89 8800.00%
FCSMF 0.40 566.67%
GGCPF 0.06 500.00%
CVAT 0.06 500.00%
TMRC 1.83 490.32%
WECFF 0.05 400.00%
EWLUD 0.45 275.00%
CNTRF 0.07 250.00%
NRRSF 0.76 245.45%
DGTHF 0.03 200.00%
 
OTCQB USA Top Losers Stocks
HLOGF 0.00 -100.00%
ALPP 3.56 -100.00%
ALPP 3.56 -100.00%
QRON 0.01 -85.71%
PGTK 0.10 -81.82%
AMMX 0.08 -80.95%
FYIRF 0.01 -75.00%
GOCOF 0.01 -75.00%
FNAUF 0.12 -60.00%
USDR 0.08 -55.56%
 
 
PPCB
Daily Charts
PPCB
Intraday Charts
Whats New @
Bazaartrend
PPCB
Free Analysis
 
PPCB Important Levels Intraday
RESISTANCE1.70
RESISTANCE1.66
RESISTANCE1.64
RESISTANCE1.61
SUPPORT1.55
SUPPORT1.52
SUPPORT1.50
SUPPORT1.46
 
PPCB Forecast December 2025
4th UP Forecast20.37
3rd UP Forecast14.34
2nd UP Forecast10.62
1st UP Forecast6.89
1st DOWN Forecast-3.73
2nd DOWN Forecast-7.46
3rd DOWN Forecast-11.18
4th DOWN Forecast-17.21
 
PPCB Weekly Forecast
4th UP Forecast20.37
3rd UP Forecast14.34
2nd UP Forecast10.62
1st UP Forecast6.89
1st DOWN Forecast-3.73
2nd DOWN Forecast-7.46
3rd DOWN Forecast-11.18
4th DOWN Forecast-17.21
 
PPCB Forecast2025
4th UP Forecast20.37
3rd UP Forecast14.34
2nd UP Forecast10.62
1st UP Forecast6.89
1st DOWN Forecast-3.73
2nd DOWN Forecast-7.46
3rd DOWN Forecast-11.18
4th DOWN Forecast-17.21
 
 
PPCB Other Details
Segment EQ
Market Capital 1397359.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
PPCB Address
PPCB
 
PPCB Latest News
 
Your Comments and Response on Propanc Biopharma Inc
 
PPCB Business Profile
Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of JaƩn to commence the POP1 joint drug discovery program. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia. Address: 302, 6 Butler Street, Camberwell, VIC, Australia, 3124
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service